By establishing HCC PDOs, Wang et al. (2020); Leung et al. (2020) found reactivation of Hedgehog signaling and receptor tyrosine kinase-induced MEK/ERK and AKT signaling pathways may be related to sorafenib resistance in HCC. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.